Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Cell & Gene Therapy Core

Cell, gene-editing, virus and vector tools for your research.

From the first of January 2022 the former iPSC, CRISPR, vector and AAV cores will merge into the new Cell and Gene Therapy Core. We will retain all the services plus we will add new ones such as iPSC-gene edits and selected iPSCs differentiation. 

schematic of the core areas

Illustration by Marie Jönsson

The Cell and Gene Therapy core is an open-access infrastructure and offering virus & vector production, iPS reprogramming, iPS-edits and differentiation and CRISPR experimental design for members of the SCC as well as national and international users.

We are a state-of-the art unit that can provide complete services from idea to finished products. We will aid in design of the project and its constituents (e.g. gRNA and plasmids), the manufacture or purchase of required components (e.g., plasmids, viruses, Cas9), cell manipulation (gene-edits, transduction, reprogramming, selection), cell harvest and differentiation into other cell types (service in progress). We will also offer partial services and access to gene editing and iPS-facilities, depending on individual needs.

We look forward to working with you to create tools for your research and strive for research excellence!

 

 

News from the Core

Dec 17th 2021 - Merry Christmas!

group picture